 IRVINE, Calif., March 09, 2022 GLOBE NEWSWIRE -- Tarsus Pharmaceuticals, Inc. NASDAQ: TARS, whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced management will present at the following conferences: 